Market Size – USD 9.89 billion in 2019, Market Growth – CAGR of 9.6%, Market Trends – Rise in incidence of cancer across the globe, increasing demand for personalized medicine and Rise in the adoption of the cancer profiling methods by oncologists.
The Cancer Tumor Profiling Market is expected to reach USD 31.99 Billion by 2027, according to a new report by Emergen Research. This market’s growth is attributed to the increasing use of biomarkers in cancer profiling, eventually rising adoption of proteomic methods for biomarker research, thus helping to increase the drug development process over the estimated period. The growing demand for personalized medicine and the rise in cancer incidence across the globe is augmenting the demand for the industry. According to the World Health Organization (WHO), Lung and Breast cancer is a common type of cancer, with around 2.09 million cases every year. The growing demand for cancer tumor profiling is driving the market for the estimated period.
#Cancer Tumor Profiling Market Report to grow your business needs: Now Purchase @ https://www.emergenresearch.com/select-license/50
Key participants include Caris Life Sciences, Foundation Medicine, GenomeDX, Genomic Health, Guardant Health, Helomics Corporation, HTG Molecular Diagnostics, Inc., Nanostring Technologies, Neogenomics Inc., Oxford Gene Technology, Qiagen N.V., Ribomed Biotechnologies Inc., among others.
Market Segments
The global Cancer Tumor Profiling market has been categorized based on the product type, application, and region. Our expert analysts undertake a thorough assessment of all of the segments included in the report and analyze them based on their market share, revenue, market growth rate, and other vital factors. The segmentation allows the interested parties to determine sectors in the global Cancer Tumor Profiling market with high growth prospects and understand the growth strategies adopted by leading segments during the forecast period.
Get access to FREE Sample PDF Copy of Cancer Tumor Profiling Market at https://www.emergenresearch.com/request-sample-form/50
Regional Outlook (Revenue in Million USD; 2017–2027)
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Technique Type Outlook (Revenue, USD Billion; 2017-2027)
Genomics
Epigenetics
Metabolomics
Proteomics
Technology Outlook (Revenue, USD Billion; 2017-2027)
Immunoassays
In Situ Hybridization
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization (CISH)
Microarray
Polymerase Chain Reaction (PCR)
Sequencing Technologies
Next Generation Sequencing(NGS)
Pyro Sequencing
Sanger Sequencing
Other Technologies
Application Outlook (Revenue, USD Billion; 2017-2027)
Research Application
Biomarker Discovery
Personalized Cancer Medicine
Clinical Application
Oncological Diagnostics
Prognostics
Monitoring and Treatment
Screening
Browse complete report description and visit our website @ https://www.emergenresearch.com/industry-report/cancer-tumor-profiling-market
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Cancer Tumor Profiling Market Segmentation & Impact Analysis
4.1. Cancer Tumor Profiling Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increase in the demand for next-generation sequencing technique in cancer profiling
4.2.2.2. Increase in the use of biomarkers in cancer profiling
4.2.2.3. Rise in incidence of cancer across the globe
4.2.2.4. Rise in the adoption of the cancer profiling methods by oncologists
4.2.3. Market restraints analysis
4.2.3.1. High capital investment
4.2.3.2. Technical issues with sample collection and storage
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Cancer Tumor Profiling Market By Technique Type Insights & Trends, Revenue (USD Million)
5.1. Technique Type Dynamics & Market Share, 2019 & 2027
5.1.1. Genomics
5.1.2. Epigenetics
5.1.3. Metabolomics
5.1.4. Proteomics
Chapter 6. Cancer Tumor Profiling Market By Technology Insights & Trends Revenue (USD Million)
6.1. Technology Dynamics & Market Share, 2019 & 2027
6.1.1. Immunoassays
6.1.2. In Situ Hybridization
6.1.2.1. Fluorescence In Situ Hybridization (FISH)
6.1.2.2. Chromogenic In Situ Hybridization (CISH)
6.1.3. Microarray
6.1.4. Polymerase Chain Reaction (PCR)
6.1.5. Sequencing Technologies
6.1.5.1. Next Generation Sequencing(NGS)
6.1.5.2. Pyro Sequencing
6.1.5.3. Sanger Sequencing
6.1.6. Other Technologies
Chapter 7. Cancer Tumor Profiling Market By Application Insights & Trends, Revenue (USD Million)
7.1. Application Dynamics & Market Share, 2019 & 2027
7.1.1. Research Application
7.1.1.1. Biomarker Discovery
7.1.1.2. Personalized Cancer Medicine
7.1.2. Clinical Application
7.1.2.1. Oncological Diagnostics
7.1.2.2. Prognostics
7.1.2.3. Monitoring and Treatment
7.1.2.4. Screening
Continue…
Related Reports:
Water and Wastewater Treatment Market To Be Worth USD 472.53 Billion by 2027 | Emergen Research
Urban Air Mobility Market To Be Worth USD 15.54 Billion by 2030 | Emergen Research
Tungsten Carbide Market Worth USD 27.70 Billion By 2027 Growing at a CAGR of 8.5% | Emergen Research
Molecular Forensics Market Size Worth USD 2,223.7 Million by 2027 Growing at a CAGR of 9.8% | Emergen Research
Anti Fingerprint Coatings Market Size Worth USD 1,297.8 Million by 2027 | Emergen Research
Big Data in Healthcare Market Size Worth USD 78.03 Billion by 2027 | Emergen Research